← FDA Drug Approvals (Drugs@FDA)

NAPROXEN

ANDA · Abbreviated New Drug Application (Generic) · Sponsor: HETERO LABS LTD III · Approved 2022-06-07

Drug application

FDA Application #

ANDA215776

Application type

Abbreviated New Drug Application (Generic)

Brand name

NAPROXEN

Generic name

NAPROXEN

Active ingredients

NAPROXEN

Dosage form

SUSPENSION

Route

ORAL

Marketing status

Prescription

Sponsor

HETERO LABS LTD III

Manufacturer

Camber Pharmaceuticals, Inc.

First approval

2022-06-07

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown